EGF, epidermal growth factor, 1950

N. diseases: 774; N. variants: 33
Disease: Diabetic foot ulcer ×
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C1456868
Disease: Diabetic foot ulcer
Diabetic foot ulcer 		0.070 Biomarker disease BEFREE This study aimed to investigate the long-term outcomes after intralesional epidermal growth factor injections in the treatment of diabetic foot ulcers. 30612874 2019
CUI: C1456868
Disease: Diabetic foot ulcer
Diabetic foot ulcer 		0.070 Biomarker disease BEFREE Therapeutic effect of the epidermal growth factor on diabetic foot ulcer and the underlying mechanisms. 30783432 2019
CUI: C1456868
Disease: Diabetic foot ulcer
Diabetic foot ulcer 		0.070 AlteredExpression disease BEFREE Interestingly, the EGF receptor is downregulated in tissue biopsies from patients with DFUs. 31661463 2019
CUI: C1456868
Disease: Diabetic foot ulcer
Diabetic foot ulcer 		0.070 Biomarker disease BEFREE Topical epidermal growth factor spray for the treatment of chronic diabetic foot ulcers: A phase III multicenter, double-blind, randomized, placebo-controlled trial. 29902542 2018
CUI: C1456868
Disease: Diabetic foot ulcer
Diabetic foot ulcer 		0.070 Biomarker disease BEFREE Altogether, our results indicate that epidermal growth factor intra-ulcer therapy contributes to restore systemic redox balance in patients with DFUs. 27002919 2017
CUI: C1456868
Disease: Diabetic foot ulcer
Diabetic foot ulcer 		0.070 Biomarker disease BEFREE Diabetic Foot Ulcers and Epidermal Growth Factor: Revisiting the Local Delivery Route for a Successful Outcome. 28904951 2017
CUI: C1456868
Disease: Diabetic foot ulcer
Diabetic foot ulcer 		0.070 Biomarker disease BEFREE <b>Objectives:</b> To explore whether Heberprot-P (an epidermal growth factor) is a cost-effective option for the treatment of advanced diabetic foot ulcer as an add-on therapy to good wound care (GWC) in Slovakia from the perspective of health care payers. 29311943 2017